Brief: Briacell Therapeutics Says Units Priced At $4.50 Each For Gross Proceeds Of $13.8 Million
25/04/2025 01:02
April 24 (Reuters) - Briacell Therapeutics Corp BCT.TO: BRIACELL THERAPEUTICS ANNOUNCES PRICING OF $13.8 MILLION PUBLIC OFFERING BRIACELL THERAPEUTICS CORP - UNITS PRICED AT $4.50 EACH FOR GROSS PROCEEDS OF $13.8 MILLION Source text: ID:nGNX7B04rQ Further company coverage: BCT.TO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Briacell Therapeutics
See all newsBrief: Briacell Therapeutics Prices 1.45 Million Common Shares At $3.25 Per Share
Brief: Briacell Receives Positive Recommendation From Data Safety Monitoring Board (Dsmb) For Phase 3 Study In Metastatic Breast Cancer
Brief: Briacell Expands Pipeline To Include An Ovarian Cancer Immunotherapy Candidate, Bria-Ova+™
Brief: Briacell Phase 3 Bria-Imt™ Study Enrollment Surpasses 230 Patients
Brief: Briacell Adds Nyu Langone Health’S Perlmutter Cancer Center As Clinical Site In Pivotal Phase 3 Breast Cancer Study